Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

A Multimodality Approach to Assessing Factor I Genetic Variants in Atypical Hemolytic Uremic Syndrome.

Java A, Pozzi N, Love-Gregory LD, Heusel JW, Sung YJ, Hu Z, Bertram P, Liszewski MK, Cline LM, Ren Z, Atkinson JP.

Kidney Int Rep. 2019 Apr 9;4(7):1007-1017. doi: 10.1016/j.ekir.2019.04.003. eCollection 2019 Jul. No abstract available.

2.

Cardiac amyloidosis in aortic stenosis-icebergs and Archimedes' principle.

Java AP, Greason KL, Dispenzieri A, Grogan M, Maleszewki JJ, Daly RC, Eleid MF, Schaff HV.

J Thorac Cardiovasc Surg. 2018 Sep;156(3):966-967. doi: 10.1016/j.jtcvs.2018.04.052. No abstract available.

PMID:
30119291
3.

Aortic valve replacement in patients with amyloidosis.

Java AP, Greason KL, Dispenzieri A, Grogan M, King KS, Maleszewski JJ, Daly RC, Eleid MF, Pochettino A, Schaff HV.

J Thorac Cardiovasc Surg. 2018 Jul;156(1):98-103. doi: 10.1016/j.jtcvs.2017.12.048. Epub 2017 Dec 19.

PMID:
29397971
4.

Complement Dysregulation and Disease: Insights from Contemporary Genetics.

Liszewski MK, Java A, Schramm EC, Atkinson JP.

Annu Rev Pathol. 2017 Jan 24;12:25-52. doi: 10.1146/annurev-pathol-012615-044145. Epub 2016 Dec 5. Review.

5.

Mapping rare, deleterious mutations in Factor H: Association with early onset, drusen burden, and lower antigenic levels in familial AMD.

Wagner EK, Raychaudhuri S, Villalonga MB, Java A, Triebwasser MP, Daly MJ, Atkinson JP, Seddon JM.

Sci Rep. 2016 Aug 30;6:31531. doi: 10.1038/srep31531.

6.

A Familial C3GN Secondary to Defective C3 Regulation by Complement Receptor 1 and Complement Factor H.

Chauvet S, Roumenina LT, Bruneau S, Marinozzi MC, Rybkine T, Schramm EC, Java A, Atkinson JP, Aldigier JC, Bridoux F, Touchard G, Fremeaux-Bacchi V.

J Am Soc Nephrol. 2016 Jun;27(6):1665-77. doi: 10.1681/ASN.2015040348. Epub 2015 Oct 15.

7.

Role of complement receptor 1 (CR1; CD35) on epithelial cells: A model for understanding complement-mediated damage in the kidney.

Java A, Liszewski MK, Hourcade DE, Zhang F, Atkinson JP.

Mol Immunol. 2015 Oct;67(2 Pt B):584-95. doi: 10.1016/j.molimm.2015.07.016. Epub 2015 Aug 7.

8.

Cytomegalovirus-induced thrombotic microangiopathy after renal transplant successfully treated with eculizumab: case report and review of the literature.

Java A, Edwards A, Rossi A, Pandey R, Gaut J, Delos Santos R, Miller B, Klein C, Brennan D.

Transpl Int. 2015 Sep;28(9):1121-5. doi: 10.1111/tri.12582. Epub 2015 Apr 24. Review.

9.

Defective complement inhibitory function predisposes to renal disease.

Java A, Atkinson J, Salmon J.

Annu Rev Med. 2013;64:307-24. doi: 10.1146/annurev-med-072211-110606. Epub 2012 Nov 1. Review.

10.

De novo membranoproliferative glomerulonephritis III in a renal transplant patient: case report and review of the literature.

Java A, Gaut JP, Brennan DC.

Transpl Int. 2012 May;25(5):e58-61. doi: 10.1111/j.1432-2277.2012.01452.x. Epub 2012 Mar 1. Review.

11.

Positive allosteric modulators of the human sweet taste receptor enhance sweet taste.

Servant G, Tachdjian C, Tang XQ, Werner S, Zhang F, Li X, Kamdar P, Petrovic G, Ditschun T, Java A, Brust P, Brune N, DuBois GE, Zoller M, Karanewsky DS.

Proc Natl Acad Sci U S A. 2010 Mar 9;107(10):4746-51. doi: 10.1073/pnas.0911670107. Epub 2010 Feb 19.

Supplemental Content

Support Center